PTC Therapeutics is Drug Discovery in United States that focus on PTC Therapeutics Inc business. Founded in 1998. They cover business area such as PTC Therapeutics Inc, development, commercialization, orally administer, small-molecule therapeutic, its target area, RNA biology post-transcriptional control process, a cell, dna, multiple therapeutic area, rare disorder, nonsense mutation, Duchenne muscular dystrophy, oncology.
1998
( 26 years old in 2024 )
PTC Therapeutics Inc
-
100 Corporate Court
South Plainfield, NJ 07080
United States
Private
PTC Therapeutics Incdevelopmentcommercializationorally administer, small-molecule therapeuticits target areaRNA biology post-transcriptional control processa celldnamultiple therapeutic arearare disordernonsense mutationDuchenne muscular dystrophyoncology
* We use standard office opening hours in near PTC Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PTC Therapeutics is Drug Discovery business from United States that founded in 1998 (26 years old in 2024), PTC Therapeutics business is focusing on PTC Therapeutics Inc.
PTC Therapeutics headquarter office and corporate office address is located in 100 Corporate Court South Plainfield, NJ 07080 United States.
PTC Therapeutics was founded in United States.
In 2024, PTC Therapeutics is currently focus on PTC Therapeutics Inc sector.
Above is snippet of Google Trends for "PTC Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PTC Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
